Navigation Links
ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
Date:4/8/2010

ClearTrial software brings dramatic efficiency gains to clinical operations and outsourcing for biopharmaceutical and medical device companies.

Chicago, IL (PRWEB) April 8, 2010 -- ClearTrial (www.cleartrial.com), the leading provider of Clinical Trial Operations (CTO) software, today announced that it will be demonstrating the software's capabilities to drive greater efficiency in clinical operations and outsourcing to an audience of more than 1,800 industry professionals at the 19th Annual Partnerships in Clinical Trials conference. The event attracts clinical operations, outsourcing, project management and business development executives from trial sponsors and Clinical Research Organizations (CROs), who come together to further their industry partnerships and to share ideas on maximizing the return on investment for every clinical research dollar spent.

"Conference attendees will see firsthand how ClearTrial software delivers efficiency gains such as the -1% cost variance on a $130 million clinical trial portfolio achieved by one Top 20 sponsor," noted ClearTrial CEO Mike Soenen. "The company used the ClearTrial software, with its embedded industry intelligence and activity-based costing architecture, to generate independent cost, resource, and timeline forecasts -- achieving better cost control and adding speed and accuracy to clinical operations and outsourcing."

During the conference, attendees can also learn how companies are leveraging ClearTrial software to gain the benefits of:

 

    Source: PRWeb
    Copyright©2010 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
    2. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
    3. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
    4. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
    5. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
    6. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
    7. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
    8. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
    9. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
    10. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
    11. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... , March 27, 2015  Neogen Corporation (NASDAQ: ... has adopted a prearranged trading plan in accordance with ... , Chairman and CEO of Neogen Corporation, is a ... Neogen Corporation common stock. Herbert does not ... was appropriate. The filing is only for a portion ...
    (Date:3/27/2015)... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... platform company serving the global pharmaceutical, biotechnology, and ... New Drug (IND) application for WuXi MedImmune,s novel ... accepted for review by the China Food and ... 2012, MedImmune, the global biologics research and development ...
    (Date:3/26/2015)... March 26, 2015 PRC Clinical, a ... today several management and executive appointments effective immediately. , ... Officer (CFO) and member of the Board of Directors. ... Operations, and Sue Dowden will assume the position of ... current Chief Operations Officer (COO), has been appointed to ...
    (Date:3/26/2015)... and CINCINNATI , March ... (LSE: SHP, NASDAQ: SHPG ) and Cincinnati ... broad research collaboration for rare diseases. The goal of ... therapies to treat rare diseases with high unmet ... with Cincinnati Children,s research expertise. As a nationally ...
    Breaking Biology Technology:Neogen CEO adopts 10b5-1 Trading Plan 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5
    ... West Michigan Science,& Technology Initiative and EDF Ventures ... medical device company, TransCorp, Inc. TransCorp is,temporarily located ... in,Grand Valley State University,s Cook-DeVos Center for Health ... novel surgical instruments,and implants. Other participants in the ...
    ... No Adverse Toxic Effects, ATLANTA, Nov. 10 ... medicines for the treatment of,age-related macular degeneration (AMD), ... Subspecialty Day at the American Academy of Ophthalmology,(AAO) ... from the ASaP (Assessment,of Safety of Intravitreal POT-4 ...
    ... Targets Governments, Hospitals and Public Health Care ... ... In an effort to help government,entities, hospitals and public health care ... aggressively,educating the industry about the proper storage and handling of vaccine,materials. ...
    Cached Biology Technology:West Michigan's Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures 2Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 2Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 3Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 2Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 3
    (Date:3/24/2015)... 24, 2015   NexID Biometrics LLC, whose ... needs, today announced the beginning of shipments of version ... The company, based in Potsdam, N.Y. ... Connect:ID Expo, which began here today at the Walter ... 2.0 of its SDK boosts the accuracy rate range ...
    (Date:3/23/2015)... , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... campaign on CNBC television starting March 30 th . ... airing in New York markets. ... "We are excited about our new ad campaign following the ...
    (Date:3/19/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet ... on Washington DC,s Fox 5 News ... Next Great Thing", host Laura Evans calls the ... really big breakthrough in mobile payment.,  Award-winning ...
    Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
    ... lynx ‒ the world,s most threatened cat to extinction ... international study has found. Published today in Nature ... climate change must be incorporated in strategies to reintroduce the ... be saved. "We show that climate change could lead ...
    ... Mass. -- Painstaking new analysis of the genetic sequence ... to the male-associated Y chromosomereveals that large portions of ... in sperm production. This surprising finding, reported ... this week in the journal Nature Genetics , ...
    ... spent so far on conservation efforts for the last ... charismatic species is likely to go extinct within 50 ... for the effects of climate change. If they did, ... study with participation from the Centre for Macroecology, Evolution ...
    Cached Biology News:Iberian lynx threatened by climate change 2Sex chromosome shocker: The 'female' X a key contributor to sperm production 2Sex chromosome shocker: The 'female' X a key contributor to sperm production 3Current efforts will not save the world's most endangered cat 2
    ... meet the needs of the ... medium supports fast cell growth ... while maintaining high cell viability ... using the Baculovirus Expression Vector ...
    Mol wt: average mol wt12,360.96 Da by calculation...
    A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
    Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
    Biology Products: